Airmed Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
About Airmed Pharmaceuticals (India)
Airmed Pharmaceuticals (India) Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2014 and has a history of Ten years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Mahankali, Prabhakar Gobburu, Nagabhushana Kurada, and Three other members serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74991TG2014PTC096836
-
Company No.
096836
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Dec 2014
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Airmed Pharmaceuticals (India)?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Mahankali
|
Additional Director | 05-Jun-2017 | Current |
|
Prabhakar Gobburu
|
Director | 15-Dec-2014 | Current |
|
Nagabhushana Kurada
|
Director | 17-May-2017 | Current |
|
Gobburu Snigdha
|
Director | 17-May-2017 | Current |
|
Sunil Madugula
|
Director | 29-May-2017 | Current |
|
Konduru Narender
|
Director | 18-May-2017 | Current |
Financial Performance of Airmed Pharmaceuticals (India).
Airmed Pharmaceuticals (India) Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Airmed Pharmaceuticals (India)?
In 2016, Airmed Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kino Black Pepper LlpRakesh Mahankali is a mutual person
-
Kh Pharma Private Limited
Sunil Madugula is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Airmed Pharmaceuticals (India)?
Unlock and access historical data on people associated with Airmed Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Airmed Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Airmed Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
